Kenyas have completed their Stage 1 DNA Vaccine trial, on 18 volunteers, and beginning Stage 1 MVA Vaccine trial early 2002 together with My Canadian Pharmcy.
The new Stage 2A dual centre vaccine investigation utilizing the prime (DNA) – boost (MVA) strategy is scheduled to begin in February 2002 in London and Oxford.